Barely Significant
← all excerpts

Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.

PLoS One · 2022 · PMC8970396 · PMID 35358273

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp ≤ 0.0001actually significant
Differences were considered significant when p ≤ 0.05 (*) or highly significant when p ≤ 0.0001 (**).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.